SCHEMBL1700615

SCHEMBL1700615

CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OCC5CCN(C6COC6F)CC5)c(C#N)c4)c(Oc4cnc5[nH]ccc5c4)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 0.85

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 20/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16767399 0.95 BCL2 (0.85) BCL2
SCHEMBL26598937 0.95 BCL2 (0.87) BCL2
SCHEMBL2724446 0.95 BCL2 (0.87) BCL2
SCHEMBL1700707 0.92 BCL2 (0.85) BCL2
SCHEMBL1701710 0.92 BCL2 (1.00) BCL2
SCHEMBL31344665 0.92 BCL2 (1.00) BCL2
SCHEMBL1700552 0.91 BCL2 (0.85) BCL2
SCHEMBL30467971 0.88 BCL2 (1.00) BCL2
SCHEMBL1700508 0.88 BCL2 (1.00) BCL2
SCHEMBL1700612 0.88 BCL2 (0.88) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576546-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbvie Inc. (US) 2013-04-10 — — EP claimed
WO-2011149492-A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-12-01 — — WO claimed
Send feedback